quinaband

contains zinc oxide, chloroiodohydroxyquinoline, calamine, gum acacia, boric acid, glycerin, & propyl hydroxybenzoate; induces thrombocytopenic purpura when applied topically; ascribed to iodochlorhydroxyquin component

Also Known As:

8-Quinolinol, 5-chloro-7-iodo-, mixt. with calamine (pharmaceutical preparation) and zinc oxide; 8-Quinolinol, 5-chloro-7-iodo-, mixt. with calamine (pharmaceutical preparation) and zinc oxide (ZnO)

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Ulcer 09/01/1968 - "In 1966, the Ulcer Clinic at The Queen Elizabeth Hospital, Woodville, South Australia, introduced the application of Quinaband and Diachylon bandages as a treatment for venous ulceration. "
2.	Thrombocytopenic Purpura (Thrombopenic Purpura) 09/04/1976 - "Quinaband-induced thrombocytopenic purpura in a patient with myxoedema coma."
3.	Coma (Comas) 09/04/1976 - "Quinaband-induced thrombocytopenic purpura in a patient with myxoedema coma."